Physician profile
Christopher Steven English
NPI 1538331871
$1,966.08
in general payments reported to CMS, 2019-2025
16 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $80.49 · 2022: $1,293 · 2023: $185 · 2024: $82.81 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $1,241.01 | 2022-2025 | |
| Skeletal Dynamics INC | $149.19 | 2019-2023 | Align, Geminus, Ijs |
| Endo Pharmaceuticals INC. | $109.97 | 2019-2024 | Xiaflex |
| Integra Lifesciences Corporation | $109.05 | 2019-2024 | Integra, Tenoglide, Primatrix |
| Endo USA, INC. | $100.38 | 2024-2025 | Xiaflex |
| Orthofix Medical, INC. | $51.08 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $42.51 | 2019-2023 | Stravix |
| Depuy Synthes Sales INC. | $35.55 | 2020 | |
| Anika Therapeutics, INC. | $25.51 | 2022 | |
| Sun Pharmaceutical Industries INC. | $21.69 | 2022 | |
| Vericel Corporation | $15.81 | 2019 | |
| Axogen | $15.16 | 2019 | |
| Kci USA, INC. | $13.53 | 2023 | Prevena |
| Bioventus LLC | $13.15 | 2019 | |
| Acell, INC. | $12.60 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $9.89 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher English listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.